カテゴリー： IMARC, 世界, 医療/バイオ

幹細胞製造の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FE0140）◆商品コード：IMARC23FE0140
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：127
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社の本調査資料によると、世界の幹細胞製造市場規模が2022年を基準に123億ドルに達しています。今後、2028年には199億ドルになり、2023年から2028年の間に8.1％の成長率を示すと見込まれます。本資料では、幹細胞製造の世界市場を調査し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、製品別（消耗品、機器、幹細胞株）分析、用途別（研究用、臨床応用、細胞＆組織バンキング）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、学術機関＆受託研究機関、病院＆外科センター、細胞＆組織バンク、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下のように掲載しています。また、企業情報として、Arthrex, Smith & Nephew PLC, Medtronic PLC, Wright Medical Group, Bioventus LLC, Stryker Corporation, Mueller Sports Medicine, RTI Surgical Holdings, Breg, Conmed Corporation, Performance Health International Limited, Bauerfeind AG, KARL STORZ Gmbh & Co. kg, Zimmer Biomet Holdings, etc.などが含まれています。
・序論
・範囲・手法
・エグゼクティブサマリー
・イントロダクション
・世界の幹細胞製造市場規模：製品別
- 消耗品の市場規模
- 機器の市場規模
- 幹細胞株の市場規模
・世界の幹細胞製造市場規模：用途別
- 研究用幹細胞製造の市場規模
- 臨床応用幹細胞製造の市場規模
- 細胞＆組織バンキング用幹細胞製造の市場規模
・世界の幹細胞製造市場規模：エンドユーザー別
- 製薬＆バイオテクノロジー企業における市場規模
- 学術機関＆受託研究機関における市場規模
- 病院＆外科センターにおける市場規模
- 細胞＆組織バンクにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の幹細胞製造市場規模：地域別
- 北米の幹細胞製造市場規模
- アジア太平洋の幹細胞製造市場規模
- ヨーロッパの幹細胞製造市場規模
- 中南米の幹細胞製造市場規模
- 中東・アフリカの幹細胞製造市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

The global stem cell manufacturing market size reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Stem cells are undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, such as red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. They are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Stem cells are cryopreserved to maintain their viability and minimize genetic change and are consequently used later to replace damaged organs and tissues and treat various diseases.

Stem Cell Manufacturing Market Trends:
The global market is primarily driven by the increasing venture capital (VC) investments in stem cell research due to the rising awareness about the therapeutic potency of stem cells. Apart from this, the widespread product utilization in effective disease management, personalized medicine, and genome testing applications are favoring the market growth. Additionally, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating multiple production steps into one device is providing an impetus to the market growth. Furthermore, the increasing product utilization in the pharmaceutical industry for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is acting as another growth-inducing factor. Moreover, the increasing product application in research applications to produce new drugs that assist in improving functions and altering the progress of diseases is providing a considerable boost to the market. Other factors, including the increasing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructure, and the implementation of various government initiatives promoting public health, are anticipated to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stem cell manufacturing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Consumables
Culture Media
Others
Instruments
Bioreactors and Incubators
Cell Sorters
Others
Stem Cell Lines
Hematopoietic Stem Cells (HSC)
Mesenchymal Stem Cells (MSC)
Induced Pluripotent Stem Cells (iPSC)
Embryonic Stem Cells (ESC)
Neural Stem Cells (NSC)
Multipotent Adult Progenitor Stem Cells

Breakup by Application:

Research Applications
Life Science Research
Drug Discovery and Development
Clinical Application
Allogenic Stem Cell Therapy
Autologous Stem Cell Therapy
Cell and Tissue Banking Applications

Breakup by End User:

Pharmaceutical & Biotechnology Companies
Academic Institutes, Research Laboratories and Contract Research Organizations
Hospitals and Surgical Centers
Cell and Tissue banks
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report
1. What was the size of the global stem cell manufacturing market in 2022?
2. What is the expected growth rate of the global stem cell manufacturing market during 2023-2028?
3. What are the key factors driving the global stem cell manufacturing market?
4. What has been the impact of COVID-19 on the global stem cell manufacturing market?
5. What is the breakup of the global stem cell manufacturing market based on product?
6. What is the breakup of the global stem cell manufacturing market based on the application?
7. What is the breakup of the global stem cell manufacturing market based on the end user?
8. What are the key regions in the global stem cell manufacturing market?
9. Who are the key players/companies in the global stem cell manufacturing market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Stem Cell Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Culture Media
6.1.2.2 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Bioreactors and Incubators
6.2.2.2 Cell Sorters
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Stem Cell Lines
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Hematopoietic Stem Cells (HSC)
6.3.2.2 Mesenchymal Stem Cells (MSC)
6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
6.3.2.4 Embryonic Stem Cells (ESC)
6.3.2.5 Neural Stem Cells (NSC)
6.3.2.6 Multipotent Adult Progenitor Stem Cells
6.3.3 Market Forecast
7 Market Breakup by Application
7.1 Research Applications
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Life Science Research
7.1.2.2 Drug Discovery and Development
7.1.3 Market Forecast
7.2 Clinical Application
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Allogenic Stem Cell Therapy
7.2.2.2 Autologous Stem Cell Therapy
7.2.3 Market Forecast
7.3 Cell and Tissue Banking Applications
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical & Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hospitals and Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cell and Tissue banks
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Anterogen Co. Ltd.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bio-Techne Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Corning Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 FUJIFILM Holdings Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Lonza Group AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Sartorius AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Takara Bio Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 幹細胞製造の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Stem Cell Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 細胞療法の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • 幹細胞バンクの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 細胞分離技術の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 幹細胞製造の世界市場2023～2031：製品別、用途別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆